<!DOCTYPE html>
<html lang="en">
  <head>
    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Your Website</title>
    <link type="text/css" rel="stylesheet" href="PDT%20LAB.css">
  </head>
  <body>
    <header>
      <nav class="navbar">
        <div class="logo"><img src="https://static.wixstatic.com/media/3baf52_b0c3c03318f640eeb2d26971c56f747c%7Emv2.png/v1/crop/x_0,y_15,w_571,h_175/fill/w_200,h_63,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/%EC%97%90%EC%9D%B4%EC%97%94%EC%85%80.png"

            alt="에이엔셀.png" style="width: 100px; height: 33px;"></div>
        <div class="menu"> <a href="index.html">Home</a>
          <a href="about.html">About</a>
          <a href="PDT%20LAB.html">PDT
            LAB</a> <a href="Immune%20LAB.html">Immune
            LAB</a> <a href="r&amp;d.html">R&amp;D</a>
          <a href="#">Contact</a> </div>
      </nav>
    </header>
    <section class="content-section1" id="BG_1704872556171_27061" style="margin-top: 0px;">
      <h1 id="h4"> <span style="color: #000066;">WHAT IS PDT? </span></h1>
      <span style="color: #000066;"> </span>
      <hr class="separator"><span style="color: #000066;"> </span> </section>
    <section class="content-section" id="BG_1704872861549_59263"><br>
      <h1 id="h4"> <span style="color: #000066;" id="h8">PDT necessary for the
          Quality of Life of Cancer Patients<br>
        </span></h1>
      <span style="color: #000066;"> </span>
      <hr class="separator"><span style="color: #000066;"> </span> </section>
    <section class="content-section3" id="BG_1704894436332_71109">
      <div class="grid-item1" id="BG_1704894385798_67511">
        <!-- Content for the left grid item --><br>
      </div>
      <div class="grid-item2" id="grid-item2">
        <!-- Content for the right grid item --><br>
      </div>
      <div class="grid-item3" style="top: 102px; left: 698px; width: 417px; height: 452px;"

        id="BG_1704895095705_87691">
        <h1 id="h3"> <span style="color: #000066;">What is the advantage of
            PDT? </span></h1>
        <span style="color: #000066;"> </span>
        <p id="p3"><span style="color: #000066;"> Photoimmunotherapy </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> PDT is targeted at tumor cells it
            causes no damage to healthy tissues </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> Treatment + fluorescent diagnostics </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> PDT is cost-effective </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> cosmetic effect </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> PDT use for improve the quality of
            life </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> PDT may also be repeated and may be
            used with other therapies </span></p>
        <span style="color: #000066;"> </span>
        <p><span style="color: #000066;"> Treatment in out-patient conditions </span></p>
      </div>
    </section>
    <section class="content-section4" id="content-section4">
      <h2><br>
      </h2>
      <p id="p"><span style="color: #000066;" id="h7">How many countries use
          PDT?</span></p>
      <hr class="separator">
      <p id="img-container"> <img src="7.png"

          alt="" id="img"> </p>
      <p><span style="color: #000066;" id="h6">How many Korean Hospitals use
          PDT?</span></p>
      <hr class="separator">
      <p id="img-container"> <img src="8.png"

          alt=""> </p>
      <p><br>
      </p>
      <div class="content-box"></div>
    </section>
    <section class="content-section" id="content-section5">
      <h2>Fotoditazin/ ANCelltazin®<span style="color: rgb(77, 81, 86); font-family: &quot;Apple SD Gothic Neo&quot;, arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"><span><br>
          </span><span></span></span><span style="color: rgb(77, 81, 86); font-family: &quot;Apple SD Gothic Neo&quot;, arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"></span></h2>
      <h2> Discovery </h2>
      <p style="text-align: left;"> <b>ANCellfotozin® is the new name for
          Fotoditazin to register in Korea</b> </p>
      <p style="text-align: left;"> At the present time the company "VETA -
        GRAND" has created a photosensitizer of new generation "PHOTODITAZIN®“on
        the basis of derivatives chlorophyll A (invention patents No. 2144538
        and No. 2276976). Its properties and characteristics are substantially
        different from the most famous Russian and foreign analogues.The
        preparation "PHOTODITAZIN®" has successfully passed the full cycle of
        biomedical and clinical trials in accordance with the requirements of
        the Ministry of Public Health of the Russian Federation. </p>
      <p style="text-align: left;"> <b>Two forms of a preparation are
          registered currently: </b></p>
      <ul style="text-align: left;">
        <li>"PHOTODITAZIN® concentrate for solution for infusion</li>
      </ul>
      <p style="text-align: left;">(registration certificate No. LS-001246 from
        18.05.2012) </p>
      <ul style="text-align: left;">
        <li>"PHOTODITAZIN®" gel-penetrator light radiation</li>
      </ul>
      <p style="text-align: left;"> (registration certificate No. FSR
        2012/130043 from 03.02.2012).&nbsp;</p>
      <div class="grid-container">
        <div class="grid-item" id="grid-item4" style="text-align: center;"> <span

            style="left: 110px; width: 157px;">ANCelltazin<br>
            IIT plan<br>
            <br>
            Detailed description of Investigator Initiated Trial Plan</span></div>
        <div class="grid-item" id="grid-item5" style="text-align: center;"> <span>ANCellbio
            <br> PDT Device<br>
            <br>
            Detailed description of PDT Device</span> </div>
        <div class="grid-item" id="grid-item6"> <span>ANCelltazin<br>
            Discovery<br>
            <br>
            Detailed description of PDT cancer therapy</span> </div>
      </div>
    </section>
  </body>
</html>
